Skip to content
10-Q/A

Quarterly Report

HUBEI MINKANG PHARMACEUTICAL LTD.

0001354488-12-004811

← back to feed
Filed
Sep 11, 2012 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Aug 3, 2012 44.18M sh
Capex Q2 2012 · Jun 30, 2012 $304.08K
Capex Q2 2012 · Jun 30, 2011 $81.13K
Operating Cash Flow Q2 2012 · Jun 30, 2012 $775.33K
Operating Cash Flow Q2 2012 · Jun 30, 2011 −$11.92K
Stockholders Equity Q2 2012 · Jun 30, 2012 $8.88M
Stockholders Equity Q2 2012 · Dec 31, 2011 $7.53M
Stockholders Equity Q2 2012 · Dec 31, 2010 $7.58M
Current Liabilities Q2 2012 · Jun 30, 2012 $8.79M
Current Liabilities Q2 2012 · Dec 31, 2011 $10.32M
Total Liabilities Q2 2012 · Jun 30, 2012 $8.79M
Total Liabilities Q2 2012 · Dec 31, 2011 $10.32M
Current Assets Q2 2012 · Jun 30, 2012 $10.21M
Current Assets Q2 2012 · Dec 31, 2011 $10.44M
Total Assets Q2 2012 · Jun 30, 2012 $17.67M
Total Assets Q2 2012 · Dec 31, 2011 $17.85M
Sga Expense restated Q2 2012 · Jun 30, 2012 $752.15K
Sga Expense Q2 2012 · Jun 30, 2012 $1.41M
Sga Expense Q2 2012 · Jun 30, 2011 $535.19K
Sga Expense Q2 2012 · Jun 30, 2011 $1.02M
Rd Expense Q2 2012 · Jun 30, 2012 $20.14K
Rd Expense Q2 2012 · Jun 30, 2012 $29.47K
Rd Expense Q2 2012 · Jun 30, 2011 $4.61K
Rd Expense Q2 2012 · Jun 30, 2011 $11.03K
Net Income Q2 2012 · Jun 30, 2012 $469.81K
Net Income Q2 2012 · Jun 30, 2012 $503.24K
Net Income Q2 2012 · Dec 31, 2011 −$214.05K
Net Income Q2 2012 · Jun 30, 2011 $138.04K
Net Income Q2 2012 · Jun 30, 2011 $407.52K
Operating Income Q2 2012 · Jun 30, 2012 $413.13K
Operating Income Q2 2012 · Jun 30, 2012 $550.85K
Operating Income Q2 2012 · Jun 30, 2011 $204.33K
Operating Income Q2 2012 · Jun 30, 2011 $573.38K
Gross Profit Q2 2012 · Jun 30, 2012 $1.74M
Gross Profit Q2 2012 · Jun 30, 2012 $2.96M
Gross Profit Q2 2012 · Jun 30, 2011 $1.15M
Gross Profit Q2 2012 · Jun 30, 2011 $2.43M
Revenue Q2 2012 · Jun 30, 2012 $3.1M
Revenue Q2 2012 · Jun 30, 2012 $5.79M
Revenue Q2 2012 · Jun 30, 2011 $2.31M
Revenue Q2 2012 · Jun 30, 2011 $5.12M
Cash And Equivalents Q2 2012 · Dec 31, 2011 $3.1M
Cash And Equivalents Q2 2012 · Dec 31, 2010 $1.39M